James Crowe
Faculty Member
Last active: 3/31/2020

Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.

Willis JR, Sapparapu G, Murrell S, Julien JP, Singh V, King HG, Xia Y, Pickens JA, LaBranche CC, Slaughter JC, Montefiori DC, Wilson IA, Meiler J, Crowe JE
J Clin Invest. 2015 125 (6): 2523-31

PMID: 25985274 · PMCID: PMC4497764 · DOI:10.1172/JCI80693

MeSH Terms (8)

Complementarity Determining Regions HIV-1 HIV Antibodies HIV Envelope Protein gp160 Humans Models, Molecular Protein Structure, Tertiary Software

Connections (1)

This publication is referenced by other Labnodes entities:

Links